Investor Releases

Date Title View
21 September, 2023 ICON plc Schedules Third Quarter 2023 Earnings Conference Call
20 September, 2023 ICON Releases Expanded End-to-end Clinical Trial Tokenisation Solution
13 September, 2023 BARDA Partners With ICON to Execute Next Generation COVID-19 Vaccines Clinical Trial
06 September, 2023 ICON plc to Present at the Baird Global Healthcare Conference
26 July, 2023 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
26 July, 2023 ICON Reports Second Quarter 2023 Results
13 July, 2023 First Half of 2023 Sees ICON Recognised for CRO Excellence, Alongside Industry Awards as an Employer of Choice and for Its Creative and Digital Services
27 June, 2023 ICON plc Schedules Second Quarter 2023 Earnings Conference Call
26 June, 2023 ICON Releases Latest Version of its Digital Platform, Providing Integrated Patient Services and Harmonised Data in One Platform
26 June, 2023 ICON plc Set to Join Russell 3000® Index
31 May, 2023 ICON plc to Attend Upcoming Investor Conferences
16 May, 2023 ICON releases its 2022 ICON Cares ESG Report
26 April, 2023 ICON Reports First Quarter 2023 Results
29 March, 2023 ICON plc Schedules First Quarter 2023 Earnings Conference Call
10 March, 2023 LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology
27 February, 2023 ICON plc to Present at Upcoming Investor Conferences
22 February, 2023 ICON Reports Fourth Quarter and Full Year 2022 Results
26 January, 2023 ICON plc Schedules Fourth Quarter 2022 Earnings Conference Call
10 January, 2023 ICON Issues Financial Guidance for Full Year 2023
03 January, 2023 ICON plc to Present at the 41st Annual J.P. Morgan Healthcare Conference
Displaying 1 - 20 of 372

Search Investor